Status
Acquired by AstraZeneca on June 10, 2013
Funding Received
$232 Million in 6 Rounds from 5 Investors
Headquarters:
Redwood City, CA
Description:
Pearl develops a combination of products for the treatment of respiratory diseases, including chronic obstructive pulmonary disease.
Categories:
Health and Wellness, Medical, Pharmaceuticals, Biotechnology
Website:
http://www.pearltherapeutics.com

Company Details

Update
Founded:
2006
Employees:
1 in CrunchBase

Pearl Therapeutics is developing unique dual and triple combination products for the treatment of widely prevalent respiratory diseases, including chronic obstructive pulmonary disease.

Pearl's current focus is on making advanced inhaled therapies available to broad patient populations via familiar and accepted metered dose inhalers.

Pearl is a privately held company led by a seasoned team of respiratory product development experts. Pearl aims to offer patients and healthcare providers alternatives that better meet their needs and improve upon the safety and efficacy of existing respiratory therapeutics to achieve better clinical outcomes.

Current Team (1)

Update

Board Members and Advisors (1)

Update

Investors (5)

Update

Offices/Locations (1)

Update
  • Corporate Headquarters

    200 Saginaw Drive

    Redwood City, CA 94063

    USA

Images (1)

Update
  • 2df23e95b7f446915047f2f6d8ae0c97